Urine and Rectal STI Diagnoses among Drug-Using Transgender Women
Methods: To date, we have recruited a sample of 60 drug using TGW at risk for HIV infection or transmission into a group-based intervention with HIV/STI testing for urethral and rectal gonorrhea and chlamydia (GC/CT) and syphilis.
Results: A majority of the sample consisted of TGW of color, primarily Black (28.6%) and Latina (48.2%); the average age was 32, and 39% were HIV-positive. The most frequently reported drug used was marijuana (78.3% of participants), followed by cocaine/crack (35.0% of participants). On average, women reported 12.8 sexual partners in the prior 60 days (Mdn=5.0) and 30.7 anal/vaginal sex acts (Mdn=20.0), of which 43.9% were condomless. Prevalence of urethral NG/CT was 3.6% whereas rectal was nearly triple that (10.7%); 6.7% had an active syphilis infection and an additional 17.8% had a previously treated infection. Overall prevalence of any active STI was 19.5%, and prevalence was highest among those using drugs other than marijuana (63%), followed by club drug users (23.8%) and marijuana-only users (15.0%). STI prevalence did not significantly differ by HIV-status.
Conclusions: Drug-using TGW present with above-average rates of active and previously treated syphilis, and rectal GC/CT was more common than urethral. Providers of services for TGW should conduct routine screening for all STIs, including rectal GC/CT, and services for substance use should be offered.
Learning Areas:Assessment of individual and community needs for health education
Implementation of health education strategies, interventions and programs
Public health or related public policy
Public health or related research
Social and behavioral sciences
Describe the prevalence of syphilis, and rectal and urethral gonorrhea and chlamydia in a sample of drug-using transgender women. Discuss demographic and behavioral factors (particularly related to drug use) associated with rectal and urethral gonorrhea and chlamydia diagnosis among transgender women.
Keyword(s): STDs/STI, Drug Abuse
Qualified on the content I am responsible for because: I am a Professor, have several relevant NIH grants, and over 250 peer-reviewed publications in this area.I have a PhD and years of experience conducting research in the realm of HIV.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.